<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0008143.ref037">
 <label>37</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>dos Santos</surname>
   <given-names>ML</given-names>
  </name>, 
  <name>
   <surname>Quintilio</surname>
   <given-names>W</given-names>
  </name>, 
  <name>
   <surname>Manieri</surname>
   <given-names>TM</given-names>
  </name>, 
  <name>
   <surname>Tsuruta</surname>
   <given-names>LR</given-names>
  </name>, 
  <name>
   <surname>Moro</surname>
   <given-names>AM</given-names>
  </name>. 
  <article-title>Advances and challenges in therapeutic monoclonal antibodies drug development</article-title>. 
  <source>Braz J Pharm Sci</source>. 
  <year>2018</year>;
  <volume>54</volume>. UNSP e01007 10.1590/s2175-97902018000001007. WOS:000464304700007.
 </mixed-citation>
</ref>
